Clinical Trials Logo
  1. Home
  2. Other Surgical Procedures
  3. NCT01580176

Continuous GlucoseMonitor for Measurement of Blood Glucose Level — ContAssGlu  

Other Surgical Procedures Clinical Trial

Official title:
A Prospective Clinical Trial on Agreement to Evaluate the GlucoseMonitor, a Novel Device for Continuous Assessment of Blood Glucose Levels, in Comparison With the RAPIDLab® 1265 Blood Gas Analyser (ContAssGlu)

Clinical Trial Summary

This study will be the first study in which the new central venous microdialysis-based continuous glucose monitoring system (Continuous GlucoseMonitor) is used to investigate the performance of this Continuous GlucoseMonitor, as the measurements will be compared with a point of care reference (RAPIDLab® 1265 blood gas analyser). Further important points are also much less blood samplings / blood loss for the patient and personnel costs.

Clinical Trial Description

The current standard for measuring blood glucose concentrations on ICU is to manually draw a blood sample from an arterial catheter and analyse the sample using a point of care blood gas analyser. This technique has several disadvantages as causes considerable blood loss and does not produce a continuous blood glucose profile and it is labour intensive (multiple samples over time are needed to follow the changes in blood glucose concentration). The monitoring system (Continuous GlucoseMonitor) based on the microdialysis technique has the advantage that not blood, but a physiological fluid such as saline is used as test medium. In brief, a physiological fluid, called the perfusate is continuously perfused through the microdialysis probe. At the membrane of the probe, glucose (as other low-molecular weight molecules) diffuses from the surrounding sample into the perfusate, now called dialysate, and is transported outside the probe for ex vivo monitoring. ;

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01580176
Study type Interventional
Source University Hospital Heidelberg
Contact
Status Completed
Phase N/A
Start date March 2012
Completion date March 2013
View Details
See also
  Status Clinical Trial Phase
Completed NCT02516566 - Effects of PEEP on Optic Nerve Sheath Diameter During Robot-Assisted Laparoscopic Prostatectomy N/A
Completed NCT02429414 - Video Double-Lumen Tube Prospective Randomized Study Phase 3
Completed NCT02248688 - Gastric Artery Embolization Trial for Lessening Appetite Nonsurgically N/A
Completed NCT01309360 - Ultrasound-guided Axillary Plexus Block - Dose Reduction of Prilocaine Phase 4
Completed NCT01433029 - Objective Assessment of Technical Skills in Cardiothoracic Surgery N/A
Completed NCT02494856 - Comparison of the Clinical Efficacy of Naproxen, Associated or Not With Esomeprazol, in Lower Third Molar Removal Phase 4
Completed NCT02263443 - Appropriated Bowel Preparation Before Exploratory Laparotomy in Gynecologic Surgery N/A
Completed NCT02450487 - Influence of Genotype of CYP2C9 on Clinical Efficacy and Pharmacokinetics of Piroxicam After Lower Third Molar Surgery Phase 4
Completed NCT01726231 - Evaluation of Abdominal Wall Lifting During Laparoscopic Direct Trocar Insertion N/A
Completed NCT01643616 - Ultrasound Guided Distal Sciatic Nerve Block - a Comparison With Nerve Stimulator Technique N/A
Completed NCT02906969 - Colonoscopy Educational Video Upon Inner City Population N/A
Completed NCT02730026 - Comparison of the Clinical Efficacy of Ketoprofen, Associated or Not With Omeprazole in Lower Third Molar Removal Phase 4
Enrolling by invitation NCT02525406 - Models for Improving Operating Room Productivity: Delays, Cancellations and Pre-admission Testing
Recruiting NCT01491165 - Safety and Efficacy of Stem Cell Transplantation for Treatment of Liver Cirrhosis Phase 2/Phase 3
Active, not recruiting NCT03169127 - Clinical Pharmacogenetic of Ibuprofen After Lower Third Molar Surgeries Phase 4